BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12173193)

  • 1. Effects of phosphodiesterase III inhibition on length-dependent regulation of myocardial function in coronary surgery patients.
    De Hert SG; ten Broecke PW; Mertens E; Rodrigus IE; Stockman BA
    Br J Anaesth; 2002 Jun; 88(6):779-84. PubMed ID: 12173193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.
    Harkin CP; Pagel PS; Tessmer JP; Warltier DC
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):179-88. PubMed ID: 7475041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of beta-adrenergic stimulation on the length-dependent regulation of myocardial function in coronary surgery patients.
    De Hert SG; Van der Linden PJ; Broecke PW; Rodrigus IE; Sermeus LA; Moulijn AC; Gillebert TC
    Anesth Analg; 1999 Oct; 89(4):835-42. PubMed ID: 10512252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species-dependent pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 58993 and WIN 62005.
    Dundore RL; Pagani ED; Bode DC; Bacon ER; Singh B; Lesher GY; Buchholz RA; Silver PJ
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):14-21. PubMed ID: 7723343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Milrinone, a cyclic AMP-phosphodiesterase inhibitor, has differential effects on regional myocardial work and oxygen consumption in experimental left ventricular hypertrophy.
    Chiu WC; Kedem J; Weiss HR; Tse J; Cheinberg BV; Scholz PM
    Cardiovasc Res; 1994 Sep; 28(9):1360-5. PubMed ID: 7954646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of R 80122, enoximone, and milrinone on left ventricular phosphodiesterase isoenzymes in vitro and on contractility of normal and stunned myocardium in vivo in dogs.
    Vandeplassche GM; Hermans CF; de Chaffoy de Courcelles DR; D'Aubioul JA; Wouters LJ; De Clerck FF
    J Cardiovasc Pharmacol; 1992 May; 19(5):714-22. PubMed ID: 1381769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of phosphodiesterase type III before aortic cross-clamping preserves intramyocardial cyclic adenosine monophosphate during cardiopulmonary bypass.
    Janelle GM; Urdaneta F; Blas ML; Shryock J; Tang YS; Martin TD; Lobato EB
    Anesth Analg; 2001 Jun; 92(6):1377-83. PubMed ID: 11375808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of desflurane and sevoflurane on length-dependent regulation of myocardial function in coronary surgery patients.
    De Hert SG; Van der Linden PJ; ten Broecke PW; Vermeylen KT; Rodrigus IE; Stockman BA
    Anesthesiology; 2001 Aug; 95(2):357-63. PubMed ID: 11506106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of milrinone on left ventricular relaxation and Ca(2+) uptake function of cardiac sarcoplasmic reticulum.
    Yano M; Kohno M; Ohkusa T; Mochizuki M; Yamada J; Kohno M; Hisaoka T; Ono K; Tanigawa T; Kobayashi S; Matsuzaki M
    Am J Physiol Heart Circ Physiol; 2000 Oct; 279(4):H1898-905. PubMed ID: 11009478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Milrinone echocardiographic viability test: a pilot study.
    Dhar SC; Birnbaum Y; Hayes S; Naqvi T; Cercek B; Blanche C; Friedman A; Trento A; Siegel RJ
    J Am Soc Echocardiogr; 2001 Jul; 14(7):668-75. PubMed ID: 11447411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of length-dependent regulation of myocardial function in coronary surgery patients using transmitral flow velocity patterns.
    De Hert SG; Vander Linden PJ; ten Broecke PW; De Mulder PA; Rodrigus IE; Adriaensen HF
    Anesthesiology; 2000 Aug; 93(2):374-81. PubMed ID: 10910486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New milrinone analogues: in vitro study of structure-activity relationships for positive inotropic effect, antagonism towards endogenous adenosine, and inhibition of cardiac type III phosphodiesterase.
    Floreani M; Fossa P; Gessi S; Mosti L; Borea PA; Dorigo P
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):109-18. PubMed ID: 12595951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Length-dependent regulation of left ventricular function in coronary surgery patients.
    De Hert SG; Gillebert TC; Ten Broecke PW; Moulijn AC
    Anesthesiology; 1999 Aug; 91(2):379-87. PubMed ID: 10443600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of phosphodiesterase III inhibitor on contractility, afterload, and vascular capacitance during right heart bypass preparation.
    Tanoue Y; Morita S; Nagano I; Ochiai Y; Tominaga R; Kawachi Y; Yasui H
    Jpn J Thorac Cardiovasc Surg; 2001 Oct; 49(10):607-13. PubMed ID: 11692586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasorelaxant effect of phosphodiesterase-inhibitor milrinone in the human radial artery used as coronary bypass graft.
    He GW; Yang CQ
    J Thorac Cardiovasc Surg; 2000 May; 119(5):1039-45. PubMed ID: 10788827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating metabolic impairment and myocardial stunning with phosphodiesterase inhibitor type III, milrinone, administered prior to coronary artery occlusion in the presence of calcium channel blockade in pigs.
    Sidi A; Muehlschlegel JD; Kirby DS; Lobato EB
    Ann Card Anaesth; 2007 Jan; 10(1):34-41. PubMed ID: 17455406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of commonly used inotropes on myocardial function and oxygen consumption under constant ventricular loading conditions.
    DeWitt ES; Black KJ; Thiagarajan RR; DiNardo JA; Colan SD; McGowan FX; Kheir JN
    J Appl Physiol (1985); 2016 Jul; 121(1):7-14. PubMed ID: 27150829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postextrasystolic potentiation in patients with ischaemic heart disease: influence of inotropic agents.
    Zhang YI; Ritchie RH; Horowitz JD
    Br J Clin Pharmacol; 1995 Jul; 40(1):25-30. PubMed ID: 8527264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of vasoconstriction by phosphodiesterase III inhibitor milrinone in human conduit arteries used as coronary bypass grafts.
    He GW; Yang CQ
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):208-14. PubMed ID: 8856475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of milrinone on left ventricular end-systolic pressure-volume relationship of rat hearts in situ.
    Kishi T; Nakahashi K; Ito H; Taniguchi S; Takaki M
    Clin Exp Pharmacol Physiol; 2001 Sep; 28(9):737-42. PubMed ID: 11553033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.